BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32658413)

  • 1. SCARA5 is a Novel Biomarker in Colorectal Cancer by Comprehensive Analysis.
    Liu J; Zeng ML; Shi PC; Cao YP; Zhang JL; Xie YP
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of
    Ni Q; Li X; Huang H; Ge Z
    Front Oncol; 2023; 13():1015358. PubMed ID: 37035142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic study on expression and prognosis of E2Fs in human colorectal cancer.
    Ma Y; Wang S; Bao J; Wang C
    Int J Clin Oncol; 2022 Feb; 27(2):362-372. PubMed ID: 34661779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
    Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
    Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
    [No Abstract]   [Full Text] [Related]  

  • 6. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
    Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
    World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of
    Wang F; Cao X; Yin L; Wang Q; He Z
    DNA Cell Biol; 2020 Oct; 39(10):1813-1824. PubMed ID: 32816580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
    Zhang H; Dong S; Feng J
    J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
    Lu C; Liao W; Huang Y; Huang Y; Luo Y
    BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated NLGN1 predicts poor survival in colorectal cancer.
    Yu Q; Wang X; Yang Y; Chi P; Huang J; Qiu S; Zheng X; Chen X
    BMC Cancer; 2021 Aug; 21(1):884. PubMed ID: 34340665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer.
    Zhou FF; Huang R; Jiang J; Zeng XH; Zou SQ
    Saudi J Gastroenterol; 2018; 24(5):301-306. PubMed ID: 29873317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of NOX Family Genes and Their Clinical Significance in Colorectal Cancer.
    Cho SY; Kim JS; Eun HS; Kang SH; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY; Moon HS
    Dig Dis Sci; 2018 Sep; 63(9):2332-2340. PubMed ID: 29781053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
    Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated SPINK4 is associated with poor survival in colorectal cancer.
    Wang X; Yu Q; Ghareeb WM; Zhang Y; Lu X; Huang Y; Huang S; Sun Y; Lin J; Liu J; Chi P
    BMC Cancer; 2019 Dec; 19(1):1258. PubMed ID: 31888570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer.
    Wang YJ; Liu M; Jiang HY; Yu YW
    J Oncol; 2022; 2022():5848823. PubMed ID: 35794979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
    Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
    Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
    Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
    Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
    Liu YR; Hu Y; Zeng Y; Li ZX; Zhang HB; Deng JL; Wang G
    J Cell Biochem; 2019 Oct; 120(10):18041-18052. PubMed ID: 31297877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.